Showing results (1-10 of 205) with videos related to
Sort By:
Pageof 21
The Journal of Rheumatology|November 11, 1999
Endothelial and adrenergic dysfunction in Raynaud's phenomenon and sclerodermaR R Freedman, R Girgis, M D MayesLancet (London, England)|September 4, 1999
Acute effect of nitric oxide on Raynaud's phenomenon in sclerodermaR R Freedman, R Girgis, M D MayesThe Journal of Rheumatology|February 24, 2001
Abnormal responses to endothelial agonists in Raynaud's phenomenon and sclerodermaR R Freedman, R Girgis, M D MayesArthritis and Rheumatism|July 1, 1996
Familial aggregation of primary Raynaud's diseaseR R Freedman, M D MayesHypertension (Dallas, Tex. : 1979)|March 18, 2000
Effects of menstrual cycle and race on peripheral vascular alpha-adrenergic responsivenessR R Freedman, R GirgisCirculation|September 15, 1995
Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's diseaseR R Freedman, R P Baer, M D MayesCirculation|October 1, 1989
Induction of vasospastic attacks despite digital nerve block in Raynaud's disease and phenomenonR R Freedman, M D Mayes, S C SabharwalThe Journal of Rheumatology|October 24, 2001
Effect of temperature and modulators of protein tyrosine kinase activity on the reactivity of isolated venules in secondary Raynaud's phenomenonP B Furspan, M D Mayes, R R FreedmanRheumatology (Oxford, England)|February 8, 2005
Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenonP B Furspan, S Chatterjee, M D Mayes, et al.Environmental Health Perspectives|September 30, 1999
Epidemiologic studies of environmental agents and systemic autoimmune diseasesM D MayesPageof 21